1 / 17

Biomarker Based PGx Strategies

In this insightful presentation, Rick Hockett, MD, Chief Medical Officer of Affymetrix, explores the latest advancements in pharmacogenomics (PGx) strategies focused on biomarker discovery and application. He discusses how leveraging genetic information can optimize patient-specific drug therapies and improve clinical outcomes. By integrating biomarker-based approaches into routine practices, healthcare providers can enhance the precision of treatments, reduce adverse drug reactions, and foster personalized medicine. Join us to learn how these strategies are shaping the future of healthcare.

temima
Télécharger la présentation

Biomarker Based PGx Strategies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Biomarker Based PGx Strategies Rick Hockett, MD Chief Medical Officer Affymetrix

More Related